Celestial Biolabs Ltd. reported audited standalone earnings results for the fourth quarter and year ended March 31, 2017. For the quarter, the company reported total income from operations of INR 129.664 million compared to INR 96.192 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 15.027 million compared to INR 2.167 million a year ago. Profit from ordinary activities before tax was INR 14.857 million compared to INR 2.167 million a year ago. Net profit for the period was INR 15.624 million or INR 0.69 per diluted share compared to INR 1.754 million or INR 0.08 per diluted share a year ago. For the year, the company reported total income from operations of INR 386.623 million compared to INR 331.449 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 36.925 million compared to INR 31.391 million a year ago. Profit from ordinary activities before tax was INR 36.744 million compared to INR 18.506 million a year ago. Net profit for the period was INR 33.340 million or INR 1.48 per diluted share compared to INR 20.801 million or INR 0.92 per diluted share a year ago.